Novel Drug Delivery Systems for Releasing Growth Factors to the CNS: Focus on Alzheimer's and Parkinson's Diseases

被引：1

作者：

Herran, E. ^{[1
,2
]}

Igartua, M. ^{[1
,2
]}

Pedraz, J. L. ^{[1
,2
]}

Hernandez, R. M. ^{[1
,2
]}

机构：

[1] Univ Basque Country, UPV EHU, Sch Pharm, Lab Pharmaceut,NanoBioCel Grp, Vitoria 01006, Spain

[2] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Vitoria, Spain

来源：

MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2014年 / 14卷 / 07期

关键词：

Alzheimer's disease; central nervous system; drug delivery systems; GDNF; Parkinson's disease; VEGF; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; NEURAL STEM-CELLS; NEUROTROPHIC FACTOR; INTRANASAL DELIVERY; GENE-THERAPY; IN-VIVO; BEHAVIORAL RECOVERY; SECRETING CELLS; MOUSE MODEL;

D O I：

10.2174/1389557514666140622205058

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Alzheimer's disease (AD) and Parkinson's disease (PD) represent the most common neurodegenerative disorders and affect more than 35 million people. Due to the limited effectiveness of available treatments in halting the neurodegenerative process, new therapies, such therapies based on growth factors (GFs), have been investigated. Nevertheless, the efficacies of these new treatments depend not only on the application of neurotrophins but also on the approaches used to deliver these proteins such that they can reach the brain. This review summarises the most widely used drug delivery systems (DDSs) for releasing GFs as possible treatments for AD and PD.

引用

页码：557 / 566

页数：10

共 50 条

[31] PET imaging in neurology: Alzheimer's and Parkinson's diseases
Sarikaya, Ismet
NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (08) : 775 - 781
[32] Intranasal drug delivery for treatment of Alzheimer's disease
Fonseca, Leonor C.
Lopes, Joao A.
Vieira, Joao
Viegas, Claudia
Oliveira, Claudia S.
Hartmann, Rafael P.
Fonte, Pedro
DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2021, 11 (02) : 411 - 425
[33] Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases
Cilento, Eugene M.
Jin, Lorrain
Stewart, Tessandra
Shi, Min
Sheng, Lifu
Zhang, Jing
JOURNAL OF NEUROCHEMISTRY, 2019, 151 (04) : 397 - 416
[34] Treatment of Alzheimer's Disease and Blood-Brain Barrier Drug Delivery
Pardridge, William M.
PHARMACEUTICALS, 2020, 13 (11) : 1 - 25
[35] Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease
Rabiee, Navid
Ahmadi, Sepideh
Afshari, Ronak
Khalaji, Samira
Rabiee, Mohammad
Bagherzadeh, Mojtaba
Fatahi, Yousef
Dinarvand, Rassoul
Tahriri, Mohammadreza
Tayebi, Lobat
Hamblin, Michael R.
Webster, Thomas J.
ADVANCED THERAPEUTICS, 2021, 4 (03)
[36] Current Research on Pro-drug Therapies for Parkinson's and Alzheimer's Disease
Huo, Cui
Wu, Lei
Jiang, Zhiqiang
Yang, Jiacheng
Wang, Zhouyu
Li, Yuzhi
Qian, Shan
MEDICINAL CHEMISTRY, 2022, 18 (06) : 655 - 666
[37] Growth Factor Therapy for Parkinson's Disease: Alternative Delivery Systems
Jarrin, Sarah
Hakami, Abrar
Newland, Ben
Dowd, Eilis
JOURNAL OF PARKINSONS DISEASE, 2021, 11 : S229 - S236
[38] Neurotrophic factors in Alzheimer's and Parkinson's disease brain
Siegel, GJ
Chauhan, NB
BRAIN RESEARCH REVIEWS, 2000, 33 (2-3) : 199 - 227
[39] Treating Alzheimer's disease using nanoparticle-mediated drug delivery strategies/systems
Roghani, Aryan Kia
Garcia, Ricardo Isaiah
Roghani, Ali
Reddy, Aananya
Khemka, Sachi
Reddy, Ruhananhad P.
Pattoor, Vasanthkumar
Jacob, Michael
Reddy, P. Hemachandra
Sehar, Ujala
AGEING RESEARCH REVIEWS, 2024, 97
[40] Exosomes as drug delivery vehicles for Parkinson's disease therapy
Haney, Matthew J.
Klyachko, Natalia L.
Zhao, Yuling
Gupta, Richa
Plotnikova, Evgeniya G.
He, Zhijian
Patel, Tejash
Piroyan, Aleksandr
Sokolsky, Marina
Kabanov, Alexander V.
Batrakova, Elena V.
JOURNAL OF CONTROLLED RELEASE, 2015, 207 : 18 - 30

← 1 2 3 4 5 →